Ticker Symbol: BLCM
Bellicum Pharmaceuticals Inc
$2.04 - 04-12-2024 4 p.m. ET
Exchange: OTC MARKETS
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001358403
Company Profile
bellicum pharmaceuticals, located near the houston medical center, is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. we are developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (hsct) and car t cell therapy. we are dedicated to creating an exceptional work environment and are passionate about working to provide innovative new treatment options that can improve health and save lives.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 2710 Reed Road
Website: http://www.bellicum.com/
CEO: Richard Fair
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.15
Change:
-$0.05
(
-25.41%)
Days Range: $0.12 - $0.22
Beta: -
52wk. High: $0.59
52wk. Low: $0.12
Ytd. Change -75.41%
50 Day Moving Average: $0.31
200 Day Moving Average: $0.37
Shares Outstanding: 9496298
Valuation
Market Cap: 142.4M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A